Answers are grounded in this paper and cite their sources.
Our studies demonstrate that CD146 defines a subpopulation of hMSCs capable of bone formation and in vivo trans-endothelial migration and thus represents a population of hMSCs suitable for use in clinical protocols of bone tissue regeneration.
No takes yet. Share an insight, caveat, or question.
Harkness et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: